Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Anticonvulsants for Alcohol Dependence

About this resource:

Systematic Review

Source: The Cochrane Collaborative

Last Reviewed: Feburary 2014

Workgroups: Substance Use Workgroup

In this Cochrane systematic review, the Cochrane Collaborative found that there isn’t enough evidence to support using anticonvulsants to treat alcohol dependence. The review included studies comparing anticonvulsants with placebo and with naltrexone. Researchers concluded that, because available evidence isn’t certain, health care providers need to balance the possible benefits and risks of using anticonvulsants compared with other medicines.

Read more about this resource

Objectives related to this resource (1)

Reduce the proportion of people who had alcohol use disorder in the past year — SU‑13
Little or no detectable change

Suggested Citation

1.

Pani, P.P., Trogu, E., Pacini, M. & Maremmani, I. (2014). Anticonvulsants for alcohol dependence. Cochrane Database of Systematic Reviews, 2014 (2). DOI: 10.1002/14651858.CD008544.pub2.